Accordingly, a recent study reported that specific subsets of differentially expressed genes associated with relapse in AML only have prognostic value within specific molecular subsets (i.e., MLL rearranged) and FAB types [22]. This evidence concerns the gene KMT2A and acute myeloid leukemia.